Immunome, Inc.
IMNM
$15.67
-$0.82-4.97%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 268.04M | 317.32M | 217.30M | 240.13M | 278.35M |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 9.40M | 5.81M | 4.04M | 3.91M | 5.93M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 277.43M | 323.13M | 221.34M | 244.04M | 284.28M |
|
|||||
Total Current Assets | 277.43M | 323.13M | 221.34M | 244.04M | 284.28M |
Net Property, Plant & Equipment | 14.29M | 15.12M | 14.39M | 9.56M | 8.62M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 4.56M | 4.45M | 4.51M | 3.30M | 3.31M |
Total Assets | 296.29M | 342.69M | 240.24M | 256.90M | 296.22M |
|
|||||
Total Accounts Payable | 4.66M | 9.13M | 14.19M | 3.52M | 7.05M |
Total Accrued Expenses | 17.05M | 16.45M | 30.98M | 25.08M | 19.19M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | 63.00K | 257.00K | 295.00K |
Total Finance Division Other Current Liabilities | 1.17M | 5.23M | 9.08M | 10.67M | 13.37M |
Total Other Current Liabilities | 1.17M | 5.23M | 9.08M | 10.67M | 13.37M |
Total Current Liabilities | 22.88M | 30.80M | 54.31M | 39.53M | 39.90M |
|
|||||
Total Current Liabilities | 22.88M | 30.80M | 54.31M | 39.53M | 39.90M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 4.14M | 4.77M | 4.77M | 2.46M | 2.48M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | 4.77M | -- | -- |
Total Liabilities | 27.02M | 35.57M | 59.08M | 41.99M | 42.38M |
|
|||||
Common Stock & APIC | 870.10M | 864.54M | 696.88M | 650.36M | 642.26M |
Retained Earnings | -600.81M | -557.41M | -515.77M | -435.52M | -388.42M |
Treasury Stock & Other | -24.00K | -3.00K | 57.00K | 70.00K | 2.00K |
Total Common Equity | 269.27M | 307.13M | 181.17M | 214.91M | 253.84M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 269.27M | 307.13M | 181.17M | 214.91M | 253.84M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 269.27M | 307.13M | 181.17M | 214.91M | 253.84M |
|